LONA Insider Trading Activity and SEC Form 4 Filings
LONA insider trading summary
Over the past 12 months, insiders at LeonaBio, Inc. (LONA) reported 5 sales worth $56K by 5 insiders and 1 open-market purchase worth $9.92B by 1 insider on SEC Form 4. Net insider buying was $9.92B.
Latest LONA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 26, 2026 | David J. Portman | 10% Owner | Buy | $9.92B (3,149,470 @ $3149.47) |
| Mar 4, 2026 | Martin Javier San | Chief Medical Officer | Sell | $9K (1,720 @ $5.37) |
| Mar 4, 2026 | Kevin Church | Chief Scientific Officer | Sell | $7K (1,359 @ $5.37) |
| Mar 4, 2026 | Mark Worthington | GENERAL COUNSEL and CCO | Sell | $7K (1,328 @ $5.37) |
| Mar 4, 2026 | Robert Renninger | Chief Financial Officer | Sell | $5K (906 @ $5.37) |
| Mar 4, 2026 | Mark James Litton | PRESIDENT and CEO | Sell | $28K (5,156 @ $5.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.